Dose-comparative monotherapy trials of ZD1839 in previously treated non-small cell lung cancer patients

被引：34
|
作者：
Herbst, RS [1 ]
机构：
[1] MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 2003年 / 30卷 / 01期
关键词：
D O I：
10.1053/sonc.2003.50030
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：30 / 38
页数：9
相关论文
共 50 条
  • [21] Gefitinib ('Iressa', ZD1839) in advanced non-small-cell lung cancer patients progressed to chemotherapy
    Cortes-Funes, H
    Figueiras, MC
    Martín-Algarra, S
    Salinas, P
    Massutí, B
    Gascón, P
    Rosell, R
    BRITISH JOURNAL OF CANCER, 2003, 89 : S27 - S27
  • [22] Pseudoprogression in Previously Treated Patients with Non-Small Cell Lung Cancer Who Received Nivolumab Monotherapy
    Fujimoto, Daichi
    Yoshioka, Hiroshige
    Kataoka, Yuki
    Morimoto, Takeshi
    Hata, Tae
    Kim, Young Hak
    Tomii, Keisuke
    Ishida, Tadashi
    Hirabayashi, Masataka
    Hara, Satoshi
    Ishitoko, Manabu
    Fukuda, Yasushi
    Hwang, Moon Hee
    Sakai, Naoki
    Fukui, Motonari
    Nakaji, Hitoshi
    Morita, Mitsunori
    Mio, Tadashi
    Yasuda, Takehiro
    Sugita, Takakazu
    Hirai, Toyohiro
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (03) : 468 - 474
  • [23] Monotherapy with docetaxel in previously treated patients with advanced non-small cell lung carcinoma
    Courousis, C
    Androulakis, N
    Heras, P
    Vamvakas, I
    Metaxaris, G
    Souklakos, J
    Vlastos, F
    Dimadi, M
    Vossos, A
    Aravosita, P
    Georgopoulou, T
    Papandreou, A
    Hatzidaki, D
    Papadakis, E
    Georgoulias, V
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 571 - 574
  • [24] Efficacy of gefitinib ('Iressa', ZD1839) in non-small-cell lung cancer metastatic to the brain
    Diaz-Cantón, E
    BRITISH JOURNAL OF CANCER, 2003, 89 : S28 - S28
  • [25] Effect of gefitinib ('Iressa', ZD1839) on brain metastases in patients with advanced non-small-cell lung cancer
    Hotta, K
    Kiura, K
    Ueoka, H
    Tabata, M
    Fujiwara, K
    Kozuki, T
    Okada, T
    Hisamoto, A
    Tanimoto, M
    LUNG CANCER, 2004, 46 (02) : 255 - 261
  • [26] Treatment of non-small cell lung cancer with gefitinib ('Iressa', ZD1839): the Greek experience with a compassionate-use program
    Razis, E
    Skarlos, D
    Briasoulis, E
    Dimopoulos, M
    Fountzilas, G
    Lambropoulos, S
    Rigatos, S
    Kopterides, P
    Efstathiou, H
    Tzamakou, E
    Bakoyannis, C
    Pectasides, D
    Makatsoris, T
    Varthalitis, G
    Papadopoulos, S
    Kosmidis, R
    ANTI-CANCER DRUGS, 2005, 16 (02) : 191 - 198
  • [27] Gefitinib (ZD1839) combined with gemcitabine or vinorelbine as single-agent in elderly patients with advanced non-small cell lung cancer (NSCLC).
    Scagliotti, G
    Rossi, A
    Novello, S
    De Marinis, F
    Dogliotti, L
    Crinò, L
    Lorusso, V
    Martoni, A
    Paccagnella, A
    Gridelli, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 636S - 636S
  • [28] Getitinib (ZD1839, Iressa®) in non-small-cell lung cancer:: a review of clinical trials from a daily practice perspective
    Barlési, F
    Tchouhadjian, C
    Doddoli, C
    Villani, P
    Greillier, L
    Kleisbauer, JP
    Thomas, P
    Astoul, P
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2005, 19 (03) : 385 - 393
  • [29] Impact of ZD1839 on non-small cell lung cancer-related symptoms as measured by the functional assessment of cancer therapy-lung scale
    Celia, D
    SEMINARS IN ONCOLOGY, 2003, 30 (01) : 39 - 48
  • [30] Gefitinib ('Iressa', ZD1839) given in the 'Iressa' Expanded Access Programme in patients with non-small-cell lung cancer
    Chioni, A
    Barbieri, F
    Baldini, E
    Orlandini, C
    Ricci, S
    Conte, PF
    BRITISH JOURNAL OF CANCER, 2003, 89 : S26 - S27
12345